01Jan 2017

EVALUATION OF SYSTOLIC DYSFUNCTION IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AFTER STEM CELL TRANSPLANT: A SINGLE CENTER EGYPTIAN EXPERIENCE.

  • Clinical Hematology and Bone Marrow Transplantation Unit, Division of Internal Medicine, Ain Shams University, Cairo, Egypt.
Crossref Cited-by Linking logo

Abstract


Background: The long-term prognosis after Hematopoietic stem cell transplantation (HSCT) has greatly improved. However, HSCT survivors are at risk of developing long term complications. Cardiac complications are potentially life-threatening and there is a need to elucidate the incidence, severity and underlying mechanisms of these complications. We assessed the systolic cardiac function by echocardiography in patients who underwent autologus and allogeneic hematopoietic stem cell transplantation for lymphoproliferative disorders and evaluated the association between the conditioning regimens used and the decline in ejection fraction. Materials and methods: 100 patients were enrolled in this retrospective study, 72 patients underwent autologus and 21 patients underwent allogeneic stem cell transplantation. 39 patients had multiple myeloma, 30 patients had NHL, 21 patients had acute lymphoblastic lymphoma, 10 patients had HD. LVEF was assessed by echocardiography and compared to a healthy control group as well as 50 positive control of patients who received chemotherapy without undergoing transplant. Results: The mean ejection fraction of cases after transplant is significantly reduced compared to the negative control group, The ejection fraction decline was highly pronounced in older age groups, male patients and more in patients with larger surface area, with the use of TBI-based regimens followed by patients who received high-dose cyclophosphamide in the conditioning regimens. Conclusion: LVEF was reduced in patients with lymphoproliferative disorders after autologus and allogeneic hematopoietic stem cell transplantation and was correlated with the use of TBI-based conditioning regimens and high-dose cyclophosphamide.


References


  1. Lehmann S, Isberg B, Ljungman P, et al. Cardiac systolic function before and after hematopoietic stem cell transplantation. Bone marrow transplantation 2000; 26(2): 187-192.
  2. Morandi P, Ruffini PA, Benvenuto GM. Cardiac toxicity of high-dose chemotherapy. Bone marrow transplantation 2005; 35(4): 323-324.
  3. Roziakova L, Mistrik M,  Batorova A. Can We Predict Clinical Cardiotoxicity with Cardiac Biomarkers in Patients After Haematopoietic Stem Cell Transplantation?  Cardiovasc Toxicol 2015; 15:210–216.
  4. Hertenstein B, Stefanic M, Schmeiser T et al. Cardiac toxicity of bone marrrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994; 12:998–1004.
  5. Cuomo JR, Sharma GK, Conger PD et al. Novel concepts in radiation-induced cardiovascular disease. World journal of cardiology 2016; 26; 8(9): 504-519.
  6. Aleman BM, van den Belt-Dusebout AW, De Bruin ML et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007;109: 1878-1886.
  7. Heidenreich PA, Kapoor JR. Radiation induced heart disease: systemic disorders in heart disease. Heart 2009; 95: 252-258.
  8. Cutter DJ, Schaapveld M, Darby SC et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst 2015; 107(4):djv008.
  9. Darby SC, Ewertz M, McGale P et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. NEngl J Med2013; 368: 987-998.
  10. McGale P, Darby SC, Hall P et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 2011; 100: 167-175.
  11. Ishida S, Doki N, Shingai N et al. The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ann Hematol 2016; 95:1145-1150.
  12. Por?ba M, Ga? P, Usnarska-Zubkiewicz L. Echocardiographic evaluation of the early cardiotoxic effect of hematopoietic stem cell transplantation in patients with hematologic malignancies. Leukemia and lymphoma 2016; 57(9): 2119-2125.

Cite This Article as:


[Haitham Mohammed Abdelbary, Yasmin Ahmed Abou El Magd, Gihan Kamal Shams Eldin and Mohamed Osman Azzazi. (2017); EVALUATION OF SYSTOLIC DYSFUNCTION IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AFTER STEM CELL TRANSPLANT: A SINGLE CENTER EGYPTIAN EXPERIENCE. Int. J. of Adv. Res. 5 (1). 670-678] (ISSN 2320-5407). www.journalijar.com


DOI:


Article DOI: 10.21474/IJAR01/2797       DOI URL: http://dx.doi.org/10.21474/IJAR01/2797


Share this article